Background: Systemic lupus erythematosus (SLE) is an autoimmune disease in which cutaneous lesions occur in 72%-85% of patients. Objective: This study was conducted to determine the pattern and incidence of skin lesions in SLE patients in Ahwaz. Patients and Methods: Thirty patients with SLE fulfilling the clinical and laboratory criteria of the American Rheumatism Association who were admitted...

The authors present a 52-year-old patient with an ill-defined skin eruption that preceded mild gastrointestinal (GI) symptoms and without respiratory who tested positive for COVID-19. With this case report, we widen the spectrum of cutaneous manifestations COVID-19 infection.

-----------

Ferrous fumarate Pustular drug eruption Acute generalized exanthematous pustulosis Generalized pustular psoriasis Aoi Iti, MD, Department of Dermatology, Hirosaki University School of Medicine, 5 Zaifu-cho, Hirosaki 036 (Japan) Although ferrous agents are commonly used clinically, they rarely induce allergic skin eruptions. Moreover, drug eruptions of the pustular type are uncommon and include ...

Background: Cutaneous drug reaction is a common side effect of antiepileptic drugs (AEDs). In recent years, a significant increase in cases of cutaneous drug reaction due to AEDs and some changes in its pattern in our department have been noticed. Therefore, we carried out this study to present clinical and paraclinical characteristics of these cases. Methods: All records of patients who were h...

Henoch-Schönlein purpura is a small vessel vasculitis occurring mainly in childhood and rarely in adulthood. Typical cutaneous eruption may begin as macular or urticarial erythematous lesions progressing to a palpable purpura. In adults, the disease has a propensity to be more severe and chronic and affects mainly the ankles and feet. Bullae, vesicles and ulcers are occasionally seen in this gr...

Lichens striatus (LS) is an acquired, self-limiting inflammatory dermatosis that follows the lines of Blaschko. The etiology of the eruption is unknown, but several theories have been proposed with focus on environmental factors, viral infection, cutaneous injury, hypersensitivity, and genetic predisposition. We describe a 19-year-old woman who developed a unilateral linear eruption 17 months a...

Ustekinumab is a human immunoglobulin G1 kappa monoclonal antibody that binds to the p40 subunit of interleukins 12 and 23. Ustekinumab has been approved for the treatment of moderate-to-severe psoriasis vulgaris and has shown high efficacy with favourable risk and benefit profiles in pivotal trials for both Caucasians (1, 2) and Asians (3). We report here a case of recurrent erythema annulare ...